Anne Krogsdam

Employment

• Innsbruck Medical University

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (29)

• Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer.
  Molecular cancer 2022 DOI: 10.1186/s12943-022-01597-7
  +Save
• Exosomal mitochondrial tRNAs and miRNAs as potential predictors of inflammation in renal proximal tubular epithelial cells.
  Molecular therapy. Nucleic acids 2022 DOI: 10.1016/j.omtn.2022.04.035
  +Save
• Functional and spatial proteomics profiling reveals intra- and intercellular signaling crosstalk in colorectal cancer
  2022 DOI: 10.1101/2022.09.16.508204
  +Save
• Smooth Muscle Specific Ablation of CXCL12 in Mice Downregulates CXCR7 Associated with Defective Coronary Arteries and Cardiac Hypertrophy.
  International journal of molecular sciences 2021 DOI: 10.3390/ijms22115908
  +Save
• Correction to: Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data.
  Genome medicine 2019 DOI: 10.1186/s13073-019-0655-5
  +Save
• Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data.
  Genome medicine 2019 DOI: 10.1186/s13073-019-0638-6
  +Save
• Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade.
  Nature communications 2018 DOI: 10.1038/s41467-018-04004-2
  +Save
• Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution.
  Nature communications 2018 DOI: 10.1038/s41467-017-02424-0
  +Save
• Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data
  2017 DOI: 10.1101/223180
  +Save
• NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes.
  Cancer research 2017 DOI: 10.1158/0008-5472.can-16-2320
  +Save